R&D Systems Recombinant Human IL-21R His-tag Protein, CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems 9249R2100
DescriptionThe Recombinant Human IL-21 R His-tag Protein is derived from HEK293. The Recombinant Human IL-21 R His-tag Protein has been validated for the following applications: Bioactivity.
The product is shipped at ambient temperature.
|Lyophilized from a 0.2μm filtered solution in PBS.|
|>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.|
|CD360, CD360 antigen, IL-21 R, IL-21 receptor, IL21R, IL-21R, interleukin 21 receptor, interleukin-21 receptor, MGC10967, NILR, Novel interleukin receptor|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|<0.10 EU per 1μg of protein by LAL method|
|Measured by its ability to inhibit IL-21-dependent proliferation of N1186 human T cells Parrish-Novak, J.(2000) NatureThe ED50 for this effect is typically 0.6-3.6 μg/mL in the presence of 100 ng/mL of recombinant human IL-21.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok
For Research Use Only